Navigation Links
Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases
Date:8/12/2008

EAST SETAUKET, N.Y., Aug. 12 /PRNewswire-FirstCall/ -- Lixte Biotechnology Holdings, Inc. (OTC Bulletin Board: LIXT) announced today that it had filed a patent application for the use of compounds the company is developing for treatment of brain tumors as potential treatments for neurodegenerative diseases including Alzheimer's and Parkinson's Disease.

Dr. John S. Kovach, President and CEO of Lixte, said, "Lixte has developed a series of novel compounds that inhibit the growth of common brain cancers of adults and children in mouse models. We have now found that some variants of these compounds have effects on brain cells that are believed to be potentially useful for the treatment of common neurodegenerative brain diseases. Since Lixte is focused primarily on developing anti-cancer drugs, we are exploring partnerships with companies that have expertise and research programs in the treatment of Alzheimer's Disease."

About Lixte Biotechnology Holdings, Inc.:

Lixte Biotechnology Holdings, Inc. is a cancer therapeutics and diagnostics company. Founded as a biomarker-diagnostics company in 2005, Lixte develops new chemotherapy drugs targeting molecular abnormalities of common human cancers.

Forward-Looking Statements:

This announcement contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. For example, statements regarding the Company's financial position, business strategy and other plans and objectives for future operations, and assumptions and predictions about future product demand, supply, manufacturing, costs, marketing and pricing factors are all forward-looking statements. These statements are generally accompanied by words such as "intend," anticipate," "believe," "estimate," "potential(ly)," "continue," "forecast," "predict," "plan," "may," "will," "could," "would," "should," "expect" or the negative of such te
'/>"/>

SOURCE Lixte Biotechnology Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
2. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
3. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
4. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
5. Dr. Ari Kiev to be Featured Speaker at Biotechnology Conference Wall Street Unplugged: The Trout Group Investor Seminar in New York July 30
6. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
7. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
8. Genetic Engineering & Biotechnology News Reports on the Growing Role of Ion-Channel Studies in Global Biotech R&D
9. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
10. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
11. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009).../--ChindexInternational,Inc.,("Chindex")(Nasdaq: C...,healthcareproductsandservicesinthePeople,sRepubli...e21stAnnualPiperJaffray,"Unplugged"HealthCareConfe...Hotel. , Managementiscurrentlyscheduledtopres...-on-onemeetingsthroughouttheday.Awebcast,ofthepres...
(Date:11/24/2009)...rstCall/--Vermillion,Inc.(VRML)(PinkSheets:VRMLQ)a...isclosureStatementtoday,November24,2009,withtheUni...hearingtoconsiderapprovaloftheDisclosureStatementi...gontheconfirmationofthePlanscheduledforJanuary7,20...nfull.ThePlanisexpected,ifapproved,toallowholderso...
(Date:11/24/2009)...-FirstCall/--ThoratecCorporation(Nasdaq: THOR ),aw...rttherapiestosave,supportandrestorefailinghearts,s...perJaffrayHealthCareConferenceonTuesday,December1....financialofficer,willprovideanupdateonthecompany,b...cificStandardTime). ,, Thepresentationwillbeava...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Emergency Nurses Association Announces Corporate Supporters for 2009 Annual Conference 58031 1Emergency Nurses Association Announces Corporate Supporters for 2009 Annual Conference 58031 2Media small businesses invited to ACS webinar on green chemistry project financing 58027 1UAB research team saves turtle species on the brink 10036 1UAB research team saves turtle species on the brink 10036 2UAB research team saves turtle species on the brink 10036 3
...5 Mayo Clinic,researchers have found what may pro...ications of diabetes -- delayed gastric emptying o...models that a red blood,cell derivative increases ...stive process. The findings appear in the current ...p://www.gastrojournal.org/ )., Gastroparesis occu...
... Neurobiological,Technologies, Inc. (NTI(R)) (Nas... excess symptomatic intracranial hemorrhage in an ...) for the treatment of acute ischemic,stroke may b... of,fibrinogen and use of common blood pressure en...th World Stroke Conference in Vienna,Austria, are ...
Other Medicine Technology:Mayo Clinic Discovery May Help Diabetic Gastric Problem 2Analysis of Earlier European Stroke Trial Supports Treatment Regimen for Viprinex(TM) in Current International Phase 3 Clinical Trials 2Analysis of Earlier European Stroke Trial Supports Treatment Regimen for Viprinex(TM) in Current International Phase 3 Clinical Trials 3Analysis of Earlier European Stroke Trial Supports Treatment Regimen for Viprinex(TM) in Current International Phase 3 Clinical Trials 4
(Date:11/25/2009)...e blood pressure? This simple question has been t...Stress-related gene Modulates High Blood Pressure ...e? This simple question has been the focus of int...s for the first time established a link between a ...onse to stress in mice as well as humans. The stud...
(Date:11/25/2009)...s could lead mothers to overlook needed care, stud...y News) -- A mother,s depression can worsen her ch...eir six-month study of 262 black mothers and their...re depressive symptoms had more frequent asthma sy...ssive symptoms had less frequent asthma symptoms. ...
(Date:11/25/2009)...,Nov.25/PRNewswire-USNewswire/--TheAmericanAssocia...udActof2009,"S.2128,whichisdesignedtosubstantially...edicare.ThebillwasintroducedbySen.GeorgeLeMieux(R-...nstheAmericanAssociationforHomecareoutlinedinits13...osedtoCongressinFebruary.Thoseprovisionsincludecal...
(Date:11/25/2009)...r problems that can occur in children with autism ...ment plan that includes medication combined with a...g to Yale University researchers and their colleag...the Journal of the American Academy of Child and ... the National Institute of Mental Health (NIMH) Re...
(Date:11/25/2009)... Initiative expands to include cost-effective,...ers, and healthcare professionals in developing wo...WEB) November 25, 2009 -- Elluminate, Inc. , the ... solutions that support 21st century teaching, le...s Fire and Ice initiative was awarded iNACOL,s ...
Breaking Medicine News(10 mins):Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Mom's Depression May Worsen Child's Asthma 2Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2Health News:Parent training key to improved treatment of behavior problems in children with autism 2Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 2Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 3Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 4Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 5
...tment for polycystic kidney disease(PKD), a leadin...n identified by a research// team led by Yale bioc...roceedings of the National Academy of Sciences. ...esults in the formation of many, large fluid-fille...
...rld Vision Foundation, Incorporated (WVFI), a Gene...dollars to fight the menace// of tuberculosis (TB)...the Philippines, for a period of five years. ... aimed to fight TB, in Zamboanga City. Villa...
...ri separatist leader Syed Ali Shah Geelani, diagno...ments to go to the US or Britain// for specialized...ction of the Hurriyat Conference underwent a biops...z Akbar, Geelani's personal secretary, told IANS. ...
...fen seems to score high as an effective pain relie...injuries, as compared to acetaminophen// and codei...ne edition of the journal Pediatrics. Nearly ... Hospital of Eastern Ontario in Ottawa. The childr...
...a: The British Healthcare Mission, a seven-member ...ities in the healthcare// sector of West Bengal. ...ice companies came here Monday for an interactive ...lthcare sector. We are interested to invest in the...
...ng your teeth can set off an epileptic fit, say r...ralia, have a reason to risk brushing// their teet...esion on their brain near the hand and mouth motor...a, a neurologist at St. Vincent's Hospital Melbour...
Other Medicine News:Health News:Triptolide: A Potential Drug for Polycystic Kidney Disease 2Health News:75 Filipinos Afflicted With TB Die Everyday 2Health News:Britain to Explore Opportunities in Bengal Medical Sector 2Health News:Simple Act of Brushing Your Teeth can Trigger an Epileptic Fit, Say Experts 2
...iratory Products, ,Westmed designs, manufacturers...nesthesia and Respiratory professionals. Our missi...nce the clinician's ability to deliver quality med...om line. , ,Our web site is designed with our cus...
...ge group?, ,Babies and young children have troubl...f an MDI. , ,Dry powder devices require a high mi... , ,Traditional nebulizers have high wastage and ...or this age group are inefficient at delivering me...
...Compressor is for active patients who want to take... The compressor is small and lightweight, yet powe...e AC compatibility (100 to 240V), 12 volt DC and r...o take aerosol treatments away from home, in their...
...Compressor is for active patients who want to take... The compressor is small and lightweight, yet powe...e AC compatibility (100 to 240V), 12 volt DC and r...o take aerosol treatments away from home, in their...
Medicine Products: